SSRI and psychedelics: Difference between revisions
From BurnZero
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Many of the subjective and biological effects of classical psychedelics are blocked after administering 5HT2AR antagonists such as ketanserin.<ref>Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, Stämpfli P, et al. The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation. Curr Biol. 2017 Feb;27(3):451–7.</ref><ref>Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics Promote Structural and Functional Neural Plasticity. Cell Rep. 2018 Jun 12;23(11):3170–82.</ref> This leads to the potential for serotonin syndrome and a decrease in subjective psychedelic effects. However, there is no empirical data on the interaction between psychedelics and antidepressants, and whether this raises the risk of serotonin syndrome. | Many of the subjective and biological effects of classical psychedelics are blocked after administering 5HT2AR antagonists such as ketanserin.<ref>Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, Stämpfli P, et al. The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation. Curr Biol. 2017 Feb;27(3):451–7.</ref><ref>Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics Promote Structural and Functional Neural Plasticity. Cell Rep. 2018 Jun 12;23(11):3170–82.</ref> This leads to the potential for serotonin syndrome and a decrease in subjective psychedelic effects. However, there is no empirical data on the interaction between psychedelics and antidepressants, and whether this raises the risk of serotonin syndrome. | ||
<hr> | |||
'''References''' | '''References''' | ||
Revision as of 08:19, 20 July 2022
Many of the subjective and biological effects of classical psychedelics are blocked after administering 5HT2AR antagonists such as ketanserin.[1][2] This leads to the potential for serotonin syndrome and a decrease in subjective psychedelic effects. However, there is no empirical data on the interaction between psychedelics and antidepressants, and whether this raises the risk of serotonin syndrome.
References
- ↑ Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, Stämpfli P, et al. The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation. Curr Biol. 2017 Feb;27(3):451–7.
- ↑ Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics Promote Structural and Functional Neural Plasticity. Cell Rep. 2018 Jun 12;23(11):3170–82.